Cyclosporine: A revolution in transplantation

[1] BIOLOGICAL EFFECTS OF CYCLOSPORIN-A - NEW ANTILYMPHOCYTIC AGENT [J]. AGENTS AND ACTIONS, 1976, 6 (04): : 468 - 475

[2] CALNE RY, 1978, LANCET, V2, P1323

[3] CANAFAX DM, 1986, TRANSPLANT P, V18, P192

[4] Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients - A report of the Canadian Neoral Renal Study Group [J]. TRANSPLANTATION, 1998, 65 (04) : 505 - 510

[5] CYCLOSPORINE-A SPECIFICALLY INHIBITS FUNCTION OF NUCLEAR PROTEINS INVOLVED IN T-CELL ACTIVATION [J]. SCIENCE, 1989, 246 (4937) : 1617 - 1620

[6] KAHAN BD, 1995, TRANSPLANTATION, V59, P505

[7] KAHAN BD, 1985, SURGERY, V97, P125

[8] Sirolimus: A new agent for clinical renal transplantation [J]. TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 48 - 50

[9] KAHAN BD, 1983, TRANSPLANT P, V15, P2211

[10] KAHAN BD, 1986, TRANSPLANT P, V18, P3

[1] BIOLOGICAL EFFECTS OF CYCLOSPORIN-A - NEW ANTILYMPHOCYTIC AGENT [J]. AGENTS AND ACTIONS, 1976, 6 (04): : 468 - 475

[2] CALNE RY, 1978, LANCET, V2, P1323

[3] CANAFAX DM, 1986, TRANSPLANT P, V18, P192

[4] Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients - A report of the Canadian Neoral Renal Study Group [J]. TRANSPLANTATION, 1998, 65 (04) : 505 - 510

[5] CYCLOSPORINE-A SPECIFICALLY INHIBITS FUNCTION OF NUCLEAR PROTEINS INVOLVED IN T-CELL ACTIVATION [J]. SCIENCE, 1989, 246 (4937) : 1617 - 1620

[6] KAHAN BD, 1995, TRANSPLANTATION, V59, P505

[7] KAHAN BD, 1985, SURGERY, V97, P125

[8] Sirolimus: A new agent for clinical renal transplantation [J]. TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 48 - 50

[9] KAHAN BD, 1983, TRANSPLANT P, V15, P2211

[10] KAHAN BD, 1986, TRANSPLANT P, V18, P3